174 related articles for article (PubMed ID: 29227198)
1. Novel platinum compounds and nanoparticles as anticancer agents.
Sarkar A
Pharm Pat Anal; 2018 Jan; 7(1):33-46. PubMed ID: 29227198
[TBL] [Abstract][Full Text] [Related]
2. Platinum-based drugs: past, present and future.
Dilruba S; Kalayda GV
Cancer Chemother Pharmacol; 2016 Jun; 77(6):1103-24. PubMed ID: 26886018
[TBL] [Abstract][Full Text] [Related]
3. Polymeric drug delivery of platinum-based anticancer agents.
Haxton KJ; Burt HM
J Pharm Sci; 2009 Jul; 98(7):2299-316. PubMed ID: 19009590
[TBL] [Abstract][Full Text] [Related]
4. Nanocapsules of platinum anticancer drugs: development towards therapeutic use.
Bryde S; de Kroon AI
Future Med Chem; 2009 Nov; 1(8):1467-80. PubMed ID: 21426060
[TBL] [Abstract][Full Text] [Related]
5. Application of liposomal technologies for delivery of platinum analogs in oncology.
Liu D; He C; Wang AZ; Lin W
Int J Nanomedicine; 2013; 8():3309-19. PubMed ID: 24023517
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers for delivery of platinum anticancer drugs.
Oberoi HS; Nukolova NV; Kabanov AV; Bronich TK
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1667-85. PubMed ID: 24113520
[TBL] [Abstract][Full Text] [Related]
7. Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin.
Kelland L
Expert Opin Investig Drugs; 2007 Jul; 16(7):1009-21. PubMed ID: 17594186
[TBL] [Abstract][Full Text] [Related]
8. The resurgence of platinum-based cancer chemotherapy.
Kelland L
Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
[TBL] [Abstract][Full Text] [Related]
9. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
Johnstone TC; Suntharalingam K; Lippard SJ
Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
[TBL] [Abstract][Full Text] [Related]
10. Liposomes, a promising strategy for clinical application of platinum derivatives.
Zalba S; Garrido MJ
Expert Opin Drug Deliv; 2013 Jun; 10(6):829-44. PubMed ID: 23470129
[TBL] [Abstract][Full Text] [Related]
11. Platinum-based anticancer agents: innovative design strategies and biological perspectives.
Ho YP; Au-Yeung SC; To KK
Med Res Rev; 2003 Sep; 23(5):633-55. PubMed ID: 12789689
[TBL] [Abstract][Full Text] [Related]
12. Oral delivery of a platinum anticancer drug using lipid assisted polymeric nanoparticles.
Cheng Q; Shi H; Huang H; Cao Z; Wang J; Liu Y
Chem Commun (Camb); 2015 Dec; 51(99):17536-9. PubMed ID: 26482339
[TBL] [Abstract][Full Text] [Related]
13. Meeting report on 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy.
Kelland LR
J Inorg Biochem; 1999 Oct; 77(1-2):121-4. PubMed ID: 10626364
[TBL] [Abstract][Full Text] [Related]
14. Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs.
Boztepe T; Castro GR; León IE
Int J Pharm; 2021 Aug; 605():120788. PubMed ID: 34116182
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
16. Current status and future prospects for satraplatin, an oral platinum analogue.
Choy H; Park C; Yao M
Clin Cancer Res; 2008 Mar; 14(6):1633-8. PubMed ID: 18347164
[TBL] [Abstract][Full Text] [Related]
17. Advancements in the Use of Platinum Complexes as Anticancer Agents.
Sharma R; Singh VJ; Chawla PA
Anticancer Agents Med Chem; 2022; 22(5):821-835. PubMed ID: 34353272
[TBL] [Abstract][Full Text] [Related]
18. Biological evaluation of a novel Herceptin-platinum (II) conjugate for efficient and cancer cell specific delivery.
Huang R; Sun Y; Zhang XY; Sun BW; Wang QC; Zhu J
Biomed Pharmacother; 2015 Jul; 73():116-22. PubMed ID: 26211591
[TBL] [Abstract][Full Text] [Related]
19. Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles.
Rossi A; Di Maio M
Expert Rev Anticancer Ther; 2016 Jun; 16(6):653-60. PubMed ID: 27010977
[TBL] [Abstract][Full Text] [Related]
20. Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives.
Yu C; Wang Z; Sun Z; Zhang L; Zhang W; Xu Y; Zhang JJ
J Med Chem; 2020 Nov; 63(22):13397-13412. PubMed ID: 32813515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
